Managing Atopic Dermatitis in Skin of Color
Source : https://www.dermatologytimes.com/view/managing-atopic-dermatitis-in-skin-of-color
Despite the recent significant advances in both topical and oral dermatologic therapy, atopic dermatitis (AD) remains a difficult-to-treat skin disease and can be particularly challenging in patients with skin of color. Three experts recently convened to discuss the nuances and recent developments in the quickly evolving treatment and management of this very common and potentially debilitating skin disease.
Discussion: All dermatologists should strive to incorporate EASI, BSA, IGA, Patient-Oriented Eczema Measures, and Dermatology Life Quality Index [scores] in their clinical assessments, because what we do in research can easily translate to clinical practice."
-
Jeremy Moss, Medical director and physician3yrI agree with Dr Honig that one of the key features of AD that is vexing for skin of color patients is dyspigmentation, both hypo- and hyperpigmentation. It will be exciting to see if new non-steroid topicals that are available and in development for AD can ameliorate or help to avoid pigmentary alterations resulting from AD.
-
Barbara Honig3yrMore recent and clinically effective steroid-sparing agents, both topical like opzelura and biologics or oral JAKs, are particularly useful in treating AD in skin of color because there is no risk of steroid-induced hypopigmentation - a common occurrence (and often distressing) when topical steroids are used for prolonged periods of time in recalcitrant moderate to severe disease.